Schematic contrasting the direct pipetting of 10 mM rapamycin DMSO stock into pure PBS causing solvent shock and instant cloudiness/precipitation against a two-step serial dilution into warm serum-containing medium with rapid vortexing yielding a crystal-free working solution.
A schematic contrasting the improper protocol (storing rapamycin DMSO stock at -20°C for 6 months with repeated freeze-thaw and moisture absorption leading to drug degradation) with the validated workflow (reconstituting in anhydrous DMSO at 10 mM, single-use aliquots, stored at -80°C for up to 1 ye
Rapamycin-FKBP12 complex allosterically binds the mTOR FRB domain, sterically blocking S6K1 Thr389 phosphorylation while permitting 4E-BP1 to access the mTORC1 catalytic pocket.
Rapamycin selectively inhibits mTORC1, abolishing S6K-mediated degradation of IRS-1 and unleashing hyperactivation of PI3K and mTORC2 to phosphorylate Akt at Ser473.
A schematic comparing rapamycin handling in low-serum cell culture: the problem side shows rapamycin molecules partitioning out of aqueous media and adhering nonspecifically to untreated or treated polystyrene plate walls due to lack of carrier proteins, whereas the solution side demonstrates supple
A schematic comparing the incorrect practice of sterile-filtering an aqueous rapamycin working solution through a PVDF syringe filter (resulting in massive hydrophobic adsorption onto the membrane and an inactive, drug-depleted filtrate) versus the correct workflow (pre-filtering aqueous media throu
Rapamycin forms a high-affinity ternary complex with FKBP12 and mTORC1 that exhibits extremely slow dissociation kinetics and persistent target suppression even after extracellular drug removal.
Apparent MTT viability drop caused by assay interference rather than cell death: verify with a parallel ATP-luminescence assay, keep the DMSO vehicle constant across all wells, and add the Rapamycin working solution gently without disturbing adherent cells.
Potency loss when the Rapamycin working solution is pre-diluted into serum-rich medium: prepare a fresh concentrated working solution in serum-free medium, add it to the wells immediately before treatment, and avoid long pre-incubation of diluted drug.
Excess FKBP12 sequesters rapamycin into binary complexes that competitively block the FRB domain of mTOR, preventing productive ternary complex assembly.